✦ LIBER ✦

Is Weight-Based Dosing of Adalimumab or Certolizumab Pegol Associated With Higher Efficacy in Patients With Crohn's Disease (CD)?

✍ Scribed by Wojciech Blonski; Mark T. Osterman; Colleen M. Brensinger; Anna M. Buchner; Gary R. Lichtenstein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S1064 Certolizumab Pegol Effectiveness i

✍ Maria T. Abreu; Severine Vermeire; Paul J. Rutgeerts; Thomas A. Ullman; Douglas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Su2084 Efficacy of Certolizumab Pegol In

✍ Sandborn, William J.; Younes, Ziad H.; Pierre-Louis, Bosny; D'Haens, Geert R. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 152 KB

W1106 Increased BMI Is Not Associated wi

✍ Qumseya, Bashar; Naik, Amar S.; Ananthakrishnan, Ashwin N.; Zadvornova, Yelena; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

494 Efficacy and Safety of Certolizumab

✍ Severine Vermeire; Maria T. Abreu; Geert D'Haens; Jean-Frédéric Colombel; Krassi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 104 KB

I2,A mucosal Crohn's disease (CD)associa

✍ Landers, Carol J.; Braun, Jonathan; Targan, Stephan R. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 191 KB